Retrospective Cohort Study on the Symptomatic Recurrence Pattern after Hysteroscopic Polypectomy.

Area of Science:

• Gynecology
• Minimally Invasive Surgery

Background:

• Benign endometrial polyps are common gynecological findings.
• Hysteroscopic polypectomy is a standard treatment, but recurrence data is limited.
• Understanding recurrence factors is crucial for patient management.

Purpose of the Study:

• To determine the symptomatic recurrence rate of benign endometrial polyps after hysteroscopic polypectomy.
• To identify risk factors associated with polyp recurrence.
• To compare recurrence rates between Versapoint® and resectoscope hysteroscopic techniques.

Main Methods:

• Retrospective cohort study.
• Compared 42 women treated with a 9-mm resectoscope (2008-2015) to 151 women treated with Versapoint® (2014).
• Analyzed recurrence based on follow-up duration, polyp characteristics, and surgical technique.

Main Results:

• The first recurrence rate was 24.35%.
• Significant risk factors for recurrence included longer follow-up duration (OR=2.58), polyps causing abnormal uterine bleeding (OR=2.5), and polyp size >15 mm (OR=1.63).
• No significant difference in recurrence was observed between Versapoint® and resectoscope hysteroscopic polypectomy (P > 0.05).

Conclusions:

• Abnormal uterine bleeding, polyp size, and follow-up duration are key risk factors for endometrial polyp recurrence.
• Hysteroscopic polypectomy technique (Versapoint® vs. resectoscope) did not influence recurrence rates.
• Further research may focus on optimizing follow-up strategies based on identified risk factors.